IN8bio, Inc. (INAB) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 22.66M | 27.88M | 11.77M | 13.74M | 12.72M | 12.58M | 6.7M | 12.68M | 15.76M | 24.63M | 16.55M | 19.46M |
| Cash & Short-Term Investments | 21.94M | 27.09M | 10.69M | 13.23M | 11.89M | 11.12M | 4M | 10.22M | 13.02M | 21.28M | 12.85M | 16.99M |
| Cash Only | 21.94M | 27.09M | 10.69M | 13.23M | 11.89M | 11.12M | 4M | 10.22M | 13.02M | 21.28M | 12.85M | 16.99M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 721K | 788K | 1.08M | 515K | 427K | 298K | 177K | 529K | 539K | 270K | 262K | 277K |
| Total Non-Current Assets | 3.6M | 4.4M | 5M | 5.63M | 7.14M | 8.37M | 9.26M | 9.81M | 9.79M | 9.08M | 9.66M | 10.25M |
| Property, Plant & Equipment | 3.25M | 4.04M | 4.56M | 5.08M | 6.6M | 7.83M | 8.5M | 9.23M | 9.22M | 8.57M | 9.15M | 9.74M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 220K | 273K | 271K | 269K | 266K | 259K | 259K | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 349K | 146K | 169K | 275K | 275K | 275K | 505K | 320K | 576K | 511K | 509K | 508K |
| Total Assets | 26.27M | 32.28M | 16.77M | 19.37M | 19.87M | 20.94M | 15.97M | 22.5M | 25.55M | 33.71M | 26.21M | 29.72M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 32.19% | 54.13% | 5.02% | -13.89% | -22.23% | -37.87% | -39.08% | -24.3% | 3.53% | 2.03% | -31.72% | -4.1% |
| Total Current Liabilities | 2.16M | 3.16M | 1.7M | 1.95M | 2.96M | 3.08M | 3.63M | 4.76M | 3.84M | 5.39M | 4.69M | 3.78M |
| Accounts Payable | 449K | 309K | 204K | 379K | 575K | 389K | 1.14M | 1.44M | 1.41M | 924K | 748K | 585K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.03M | 1.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 681K | 1.63M | 418K | 404K | 115K | 207K | 0 | 1.03M | 480K | 1.67M | 1.28M | 852K |
| Current Ratio | 10.50x | 8.82x | 6.91x | 7.03x | 4.30x | 4.08x | 1.84x | 2.66x | 4.10x | 4.57x | 3.53x | 5.15x |
| Quick Ratio | 10.50x | 8.82x | 6.91x | 7.03x | 4.30x | 4.08x | 1.84x | 2.66x | 4.10x | 4.57x | 3.53x | 5.15x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.33M | 1.56M | 1.88M | 2.18M | 3.04M | 3.38M | 3.74M | 4.12M | 4.18M | 3.38M | 3.76M | 4.14M |
| Long-Term Debt | 1.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 1.56M | 1.88M | 2.18M | 3.04M | 3.38M | 3.74M | 4.12M | 4.18M | 3.38M | 3.76M | 4.14M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.48M | 4.72M | 3.58M | 4.13M | 5.99M | 6.47M | 7.38M | 8.88M | 8.02M | 8.77M | 8.45M | 7.92M |
| Total Debt | 2.35M | 2.78M | 2.96M | 3.12M | 4.27M | 5.03M | 5.47M | 5.9M | 5.71M | 4.89M | 5.26M | 5.66M |
| Net Debt | -19.59M | -24.31M | -7.73M | -10.11M | -7.62M | -6.09M | 1.47M | -4.32M | -7.3M | -16.39M | -7.59M | -11.33M |
| Debt / Equity | 0.10x | 0.10x | 0.22x | 0.20x | 0.31x | 0.35x | 0.64x | 0.43x | 0.33x | 0.20x | 0.30x | 0.26x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 22.78M | 27.56M | 13.19M | 15.24M | 13.88M | 14.48M | 8.59M | 13.62M | 17.53M | 24.94M | 17.76M | 21.8M |
| Equity Growth % | 64.16% | 90.34% | 53.57% | 11.88% | -20.82% | -41.94% | -51.64% | -37.52% | 4.4% | 9.7% | -39.93% | -17.95% |
| Book Value per Share | 1.17 | 6.30 | 2.91 | 3.70 | 0.17 | 0.26 | 0.18 | 0.30 | 0.40 | 0.70 | 0.56 | 0.77 |
| Total Shareholders' Equity | 22.78M | 27.56M | 13.19M | 15.24M | 13.88M | 14.48M | 8.59M | 13.62M | 17.53M | 24.94M | 17.76M | 21.8M |
| Common Stock | 10K | 10K | 10K | 10K | 8K | 7K | 5K | 5K | 4K | 4K | 4K | 4K |
| Retained Earnings | -146.19M | -141.1M | -136.15M | -132.3M | -127.21M | -121.66M | -115.5M | -108.41M | -99.78M | -91.22M | -83.62M | -76.45M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |